Request Demo
Last update 20 Jul 2025
Recombinant Interleukin 21(ZymoGenetics)
Last update 20 Jul 2025
Overview
Basic Info
Drug Type Interleukins |
Synonyms- |
Target |
Action agonists |
Mechanism IL-21R agonists(Interleukin 21 Receptor agonists), Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant Interleukin 21(ZymoGenetics)NCT00389285
A Phase 1/2, Open-Label, Dose Escalation Study to Assess the Safety and Pharmacokinetics of Recombinant Interleukin 21 (rIL-21) Administered Concomitantly With Sorafenib (Nexavar) in Subjects With Metastatic Renal Cell Carcinoma
100 Clinical Results associated with Recombinant Interleukin 21(ZymoGenetics)
Login to view more data
100 Translational Medicine associated with Recombinant Interleukin 21(ZymoGenetics)
Login to view more data
100 Patents (Medical) associated with Recombinant Interleukin 21(ZymoGenetics)
Login to view more data
100 Deals associated with Recombinant Interleukin 21(ZymoGenetics)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Renal Cell Carcinoma | Phase 2 | United States | 01 Oct 2006 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 40 | qowmviubyd(jzspgmhiay) = czbcgtzspj ycqgrkubrt (ojyiwnuvft ) View more | - | 20 May 2010 | |||
Phase 1 | 15 | pdggoygroo(awyxyyvvwy) = flu-like symptoms, headache, and fatigue jwatkzkguz (evkuedehct ) View more | - | 20 May 2008 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free